Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


A Study With NLY01 in Subjects With Type 2 Diabetes
Conditions:   Type2 Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: NLY01;   Drug: Placebo
Sponsor:   Neuraly, Inc.
Recruiting

Mon, 11 Nov 2019 12:00:00 EST


Control:Diabetes Pilot Study I
Conditions:   Insulin Treated Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 1
Intervention:   Other: Control:Diabetes mobile app
Sponsor:   Brigham and Women's Hospital
Recruiting

Mon, 11 Nov 2019 12:00:00 EST


Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care
Conditions:   Hypertension;   Diabetes;   Dyslipidemias
Intervention:   Device: Mobile application
Sponsor:   Universidad Miguel Hernandez de Elche
Recruiting

Mon, 11 Nov 2019 12:00:00 EST


Long-term, Implantable Sensor Improves Health Outcomes in Patients With T1D
Condition:   Diabetes Mellitus, Type 1
Intervention:   Device: Long term sensor
Sponsor:   University Magna Graecia
Completed

Mon, 11 Nov 2019 12:00:00 EST


Mindfulness IN-home for Diabetes and Sleep Health
Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Mindfulness-based stress reduction (MBSR) Intervention
Sponsors:   Emory University;   Georgia Center for Diabetes Translation Research;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Mon, 11 Nov 2019 12:00:00 EST


Study of the Psychological Profile of Type 2 Diabetic Patients With Foot Wounds, Compared to Diabetic Patients Without Foot Wounds
Conditions:   Type 2 Diabetes;   Foot Wound
Intervention:   Other: questionnaire
Sponsor:   Centre Hospitalier Universitaire Dijon
Not yet recruiting

Mon, 11 Nov 2019 12:00:00 EST


A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Type 1 Diabetes
Interventions:   Drug: Rapid-Acting Insulin;   Drug: Long acting insulin
Sponsor:   Emory University
Enrolling by invitation

Fri, 08 Nov 2019 12:00:00 EST


Imagine to Remember: Improving Medication Adherence in Pre- and Type 2 Diabetes
Condition:   Medication Adherence
Intervention:   Behavioral: Episodic Future Thinking
Sponsor:   State University of New York at Buffalo
Recruiting

Fri, 08 Nov 2019 12:00:00 EST


Context Aware Data Gathering Study
Condition:   Type 1 Diabetes
Intervention:   Other: Exercise
Sponsors:   Oregon Health and Science University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Thu, 07 Nov 2019 12:00:00 EST


Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus
Condition:   Type2 Diabetes
Intervention:   Device: data collection
Sponsors:   ValoTec;   APHP
Recruiting

Thu, 07 Nov 2019 12:00:00 EST


Mediterranean Diet Versus Exercise to Lower Cardiometabolic Risk
Conditions:   Overweight or Obesity;   Visceral Steatosis
Intervention:   Other: energy deficit
Sponsors:   Oslo University Hospital;   The National Association for Public Health, Norway
Not yet recruiting

Thu, 07 Nov 2019 12:00:00 EST


Osmotic Agent Use in Middle Cerebral Artery Stroke
Conditions:   Ischemic Stroke;   MCA Infarction
Intervention:   Other: No intervention is planned, this will be a purely retrospective trial.
Sponsor:   University of Minnesota
Completed

Thu, 07 Nov 2019 12:00:00 EST


Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1
Condition:   Type2 Diabetes Mellitus
Interventions:   Drug: Part A, Reference (D635 10/500mg, Astrazeneca);   Drug: Part B, Reference (D635 10/500mg, Astrazeneca)
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 07 Nov 2019 12:00:00 EST


The Prognostic Value of Lactate is Different Among Septic Patients With or Without Diabetes Mellitus
Conditions:   Sepsis;   Diabetes Mellitus
Intervention:  
Sponsor:   Shanghai Zhongshan Hospital
Recruiting

Thu, 07 Nov 2019 12:00:00 EST


To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Type 2 Diabetes.
Conditions:   Dyslipidemia;   Type 2 Diabetes
Interventions:   Drug: AZD8233 subcutaneous injection;   Drug: Placebo
Sponsors:   AstraZeneca;   Parexel
Not yet recruiting

Thu, 07 Nov 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA approves first therapy to treat patients with rare blood disorder
FDA grants approval to Reblozyl (luspatercept–aamt) for the treatment of anemia in adult patients with beta thalassemia who require regular red-blood cell transfusions.

Fri, 08 Nov 2019 12:28:56 EST


Statement on the agency’s efforts to protect patients through postmarket drug safety surveillance practices
Today, the FDA is issuing an update on efforts to protect patients through postmarket drug safety surveillance practices

Wed, 06 Nov 2019 15:24:27 EST


FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Today, the FDA authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. It is the first HIV drug resistance assay that uses NGS that the FDA has authorized for marketing in the U.S.

Tue, 05 Nov 2019 14:32:07 EST


Statement on new testing results, including low levels of impurities in ranitidine drugs
Today, the FDA is issuing an update on new testing results, including low levels of impurities in ranitidine drugs

Fri, 01 Nov 2019 15:49:50 EDT


USDA, EPA and FDA announce partnership with the Food Waste Reduction Alliance
New partnership with the Food Waste Reduction Alliance, the latest effort in the Winning on Reducing Food Waste Initiative launched by the three federal agencies in 2018.

Wed, 30 Oct 2019 14:06:11 EDT


Digital submission of adverse event reports for investigational new drug applications reflects FDA’s ongoing modernization efforts
FDA is taking steps towards requiring electronic submission of certain safety reports under an investigational new drug (IND) application into the FDA's Adverse Event Reporting System (FAERS).

Tue, 29 Oct 2019 16:33:04 EDT


Statement on FDA’s new report regarding root causes and potential solutions to drug shortages
Today, the FDA is issuing a report on causes and solutions to drug shortages

Tue, 29 Oct 2019 10:45:40 EDT


FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease
The U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC for illegally selling unapproved products containing cannabidiol with unsubstantiated claims.

Mon, 28 Oct 2019 13:21:02 EDT


FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

Fri, 25 Oct 2019 14:55:43 EDT


FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc.

Fri, 25 Oct 2019 14:46:13 EDT
Diabetes news from the American Diabetes Association

Latest Top (5) News